100 related articles for article (PubMed ID: 11753403)
1. All peptide-MHC complexes are not created equal.
Jensen PE
Nat Immunol; 2002 Jan; 3(1):14-5. PubMed ID: 11753403
[No Abstract] [Full Text] [Related]
2. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB
Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP
Anczurowski M; Yamashita Y; Nakatsugawa M; Ochi T; Kagoya Y; Guo T; Wang CH; Rahman MA; Saso K; Butler MO; Hirano N
Sci Rep; 2018 Mar; 8(1):4804. PubMed ID: 29555965
[TBL] [Abstract][Full Text] [Related]
4. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
[TBL] [Abstract][Full Text] [Related]
5. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules.
Hammond C; Denzin LK; Pan M; Griffith JM; Geuze HJ; Cresswell P
J Immunol; 1998 Oct; 161(7):3282-91. PubMed ID: 9759843
[TBL] [Abstract][Full Text] [Related]
6. Expression of molecules involved in antigen presentation and T cell activation (HLA-DR, CD80, CD86, CD44 and CD54) by cultured human osteoblasts.
Reyes-Botella C; Montes MJ; Vallecillo-Capilla MF; Olivares EG; Ruiz C
J Periodontol; 2000 Apr; 71(4):614-7. PubMed ID: 10807126
[TBL] [Abstract][Full Text] [Related]
7. Oncogene-derived peptides: a new class of tumor rejection antigens?
Gedde-Dahl T; Olsen BH; Thorsby E; Gaudernack G
Transplant Proc; 1993 Feb; 25(1 Pt 2):1385-6. PubMed ID: 8442151
[No Abstract] [Full Text] [Related]
8. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA-DR, DQ and DP antigens and interleukin-2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: evidence for "frustrated" activation.
Pitzalis C; Kingsley G; Lanchbury JS; Murphy J; Panayi GS
J Rheumatol; 1987 Aug; 14(4):662-6. PubMed ID: 3118018
[TBL] [Abstract][Full Text] [Related]
10. Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes.
Hall FC; Rabinowitz JD; Busch R; Visconti KC; Belmares M; Patil NS; Cope AP; Patel S; McConnell HM; Mellins ED; Sonderstrup G
Eur J Immunol; 2002 Mar; 32(3):662-70. PubMed ID: 11857340
[TBL] [Abstract][Full Text] [Related]
11. Lack of fair play in the T cell response.
Lanzavecchia A
Nat Immunol; 2002 Jan; 3(1):9-10. PubMed ID: 11753400
[No Abstract] [Full Text] [Related]
12. Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation.
Desombere I; Cao T; Gijbels Y; Leroux-Roels G
Clin Exp Immunol; 2005 Apr; 140(1):126-37. PubMed ID: 15762884
[TBL] [Abstract][Full Text] [Related]
13. Functional HLA-DM on the surface of B cells and immature dendritic cells.
Arndt SO; Vogt AB; Markovic-Plese S; Martin R; Moldenhauer G; Wölpl A; Sun Y; Schadendorf D; Hämmerling GJ; Kropshofer H
EMBO J; 2000 Mar; 19(6):1241-51. PubMed ID: 10716924
[TBL] [Abstract][Full Text] [Related]
14. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY.
Szöllósi J; Horejsí V; Bene L; Angelisová P; Damjanovich S
J Immunol; 1996 Oct; 157(7):2939-46. PubMed ID: 8816400
[TBL] [Abstract][Full Text] [Related]
15. Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes.
Ramachandra L; Song R; Harding CV
J Immunol; 1999 Mar; 162(6):3263-72. PubMed ID: 10092778
[TBL] [Abstract][Full Text] [Related]
16. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
17. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
[TBL] [Abstract][Full Text] [Related]
18. Development of T cell lines sensitive to antigen stimulation.
Williams T; Krovi HS; Landry LG; Crawford F; Jin N; Hohenstein A; DeNicola ME; Michels AW; Davidson HW; Kent SC; Gapin L; Kappler JW; Nakayama M
J Immunol Methods; 2018 Nov; 462():65-73. PubMed ID: 30165064
[TBL] [Abstract][Full Text] [Related]
19. Involvement of CD91 and scavenger receptors in Hsp70-facilitated activation of human antigen-specific CD4+ memory T cells.
Fischer N; Haug M; Kwok WW; Kalbacher H; Wernet D; Dannecker GE; Holzer U
Eur J Immunol; 2010 Apr; 40(4):986-97. PubMed ID: 20101615
[TBL] [Abstract][Full Text] [Related]
20. Differential tissue distribution of HLA-DR, -DP and -DQ antigens.
Forsum U; Claesson K; Jonsson R; Karlsson-Parra A; Klareskog L; Scheynius A; Tjernlund U
Adv Exp Med Biol; 1987; 216A():233-9. PubMed ID: 3687525
[No Abstract] [Full Text] [Related]
[Next] [New Search]